Altered responsiveness of metastatic versus non-metastatic fibroblasts to heparin-binding growth factors
- 1 November 1988
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 42 (3) , 193-197
- https://doi.org/10.1016/0304-3835(88)90304-7
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Modulation of transforming growth factor type beta action by activated ras and c-myc.Molecular and Cellular Biology, 1987
- Extended Culture of Mouse Embryo Cells Without Senescence: Inhibition by SerumScience, 1987
- Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.Molecular and Cellular Biology, 1987
- Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor.Molecular and Cellular Biology, 1986
- Purification and characterization of heparin-binding endothelial cell growth factors.Journal of Biological Chemistry, 1986
- Heparin-treated, v-myc-transformed chicken heart mesenchymal cells assume a normal morphology but are hypersensitive to epidermal growth factor (EGF) and brain fibroblast growth factor (bFGF); cells transformed by the v-Ha-ras oncogene are refractory to EGF and bFGF but are hypersensitive to insulin-like growth factors.Proceedings of the National Academy of Sciences, 1985
- The Characterization and Partial Purification of Hepatocyte Proliferation FactorAnnals of Surgery, 1985
- Autocrine growth factors and cancerNature, 1985
- Type beta transforming growth factor: a bifunctional regulator of cellular growth.Proceedings of the National Academy of Sciences, 1985